Evident with every viral pandemic including COVID-19, rapid deployment of compatible antiviral therapies is of paramount importance, particularly before a long-term strategy of a vaccine is possible. Antivirals can prevent or control viral diseases from emerging diseases, respiratory infections, chronic diseases to virus-associated tumours.
Join us on this virtual congress to get up to speed and help accelerate your antiviral research from bench to patient.
Brought to you by the team behind the global vaccine series, the congress will feature 3 tracks on:
COVID & Emerging Diseases
This is the most critical time in history for the global drug discovery and development community to come together and join us VIRTUALLY.
We will identify the urgent priorities for research, to mobilize, coordinate and align funding to enable the research needed to tackle this crisis. We commit with our experts how you can learn mechanisms for continuing scientific interactions and collaborations, now and beyond the congress.